We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
-3.24%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$73.5B
AUM Growth
-$7.73B
Cap. Flow
-$10.4B
Cap. Flow %
-14.12%
Top 10 Hldgs %
24.14%
Holding
2,549
New
227
Increased
861
Reduced
712
Closed
243

Sector Composition

Rank Sector Weight
1 Technology 19.75%
2 Healthcare 13.74%
3 Financials 13.36%
4 Industrials 11.58%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN icon
1951
Biohaven
BHVN
$2.17B
$7K ﹤0.01%
280
-18,575
-99% -$386K
IVZ icon
1952
Invesco
IVZ
$14B
$7K ﹤0.01%
534
-188,779
-100% -$3.04M
JSPR icon
1953
Jasper Therapeutics
JSPR
$21.5M
$7K ﹤0.01%
+1,114
New +$13.6K
MT icon
1954
ArcelorMittal
MT
$55.2B
$7K ﹤0.01%
280
PRQR icon
1955
ProQR Therapeutics
PRQR
$268M
$7K ﹤0.01%
6,214
+302
+5% +$475
QRVO icon
1956
Qorvo
QRVO
$8.41B
$7K ﹤0.01%
75
+5
+7% +$511
RMD icon
1957
ResMed
RMD
$32.4B
$7K ﹤0.01%
51
-5,085
-99% -$919K
RTO icon
1958
Rentokil
RTO
$12.3B
$7K ﹤0.01%
212
SCLX icon
1959
Scilex Holding
SCLX
$48.8M
$7K ﹤0.01%
162
SMWB icon
1960
Similarweb
SMWB
$646M
$7K ﹤0.01%
1,200
-13,186
-92% -$86.3K
LENZ
1961
LENZ Therapeutics
LENZ
$164M
$7K ﹤0.01%
434
+21
+5% +$365
MORF
1962
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$7K ﹤0.01%
315
TDCX
1963
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$7K ﹤0.01%
1,258
+370
+42% +$2.43K
HIBB
1964
DELISTED
Hibbett, Inc. Common Stock
HIBB
$7K ﹤0.01%
160
-12,768
-99% -$544K
AVIR icon
1965
Atea Pharmaceuticals
AVIR
$399M
$6K ﹤0.01%
2,298
-2,953
-56% -$10K
HZO icon
1966
MarineMax
HZO
$776M
$6K ﹤0.01%
208
+31
+18% +$1.08K
IOO icon
1967
iShares Global 100 ETF
IOO
$9.19B
$5K ﹤0.01%
80
+79
+7,900% +$5.99K
SLDB icon
1968
Solid Biosciences
SLDB
$857M
$5K ﹤0.01%
2,332
+116
+5% +$450
KLRS
1969
Kalaris Therapeutics
KLRS
$99.7M
$5K ﹤0.01%
109
+5
+5% +$341
ACET icon
1970
Adicet Bio
ACET
$74.1M
$4K ﹤0.01%
191
+9
+5% +$318
BHP icon
1971
BHP
BHP
$223B
$4K ﹤0.01%
84
-84
-50% -$4.91K
BUD icon
1972
AB InBev
BUD
$165B
$4K ﹤0.01%
+87
New +$4.93K
CCK icon
1973
Crown Holdings
CCK
$13.2B
$4K ﹤0.01%
54
-104,877
-100% -$9.4M
EFX icon
1974
Equifax
EFX
$20.7B
$4K ﹤0.01%
23
IMXI icon
1975
International Money Express
IMXI
$367M
$4K ﹤0.01%
250

Similar funds

Lazard Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Lazard Asset Management held 2,549 positions worth $73.5B, down 9.5% from $81.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Lazard Asset Management withdrew a net $10.4B in Q3 2023, closing 243 positions and reducing 712 holdings. Its most notable exit was Littelfuse, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lazard Asset Management opened a new position in ScottsMiracle-Gro worth $28.3M.

  • Lazard Asset Management's largest Q3 2023 buy was ScottsMiracle-Gro: 548,310 shares worth $28.3M.
  • Lazard Asset Management added most to PPL Corp in Q3 2023, an estimated $301M increase.
  • Lazard Asset Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $547M.
  • Lazard Asset Management fully exited Littelfuse in Q3 2023, selling an estimated $24.3M.
  • Lazard Asset Management's ten largest holdings make up 24% of its $73.5B portfolio in Q3 2023.
  • Lazard Asset Management opened 227 new positions and closed 243 in Q3 2023.
  • Lazard Asset Management's portfolio value fell 9.5% quarter-over-quarter to $73.5B.

Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.